These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1359751)

  • 1. An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
    Gebre-Hiwot A; Tadesse G; Croft SL; Frommel D
    Acta Trop; 1992 Aug; 51(3-4):237-45. PubMed ID: 1359751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
    Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro anti-leishmanial activity of inhibitors of ergosterol biosynthesis.
    Gebre-Hiwot A; Frommel D
    J Antimicrob Chemother; 1993 Dec; 32(6):837-42. PubMed ID: 8144423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
    Walker J; Saravia NG
    J Parasitol; 2004 Oct; 90(5):1155-62. PubMed ID: 15562618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes.
    Lucumi A; Robledo S; Gama V; Saravia NG
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1990-5. PubMed ID: 9687395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate.
    El Fadili K; Imbeault M; Messier N; Roy G; Gourbal B; Bergeron M; Tremblay MJ; Légaré D; Ouellette M
    Antimicrob Agents Chemother; 2008 Feb; 52(2):526-33. PubMed ID: 18070969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
    Jain SK; Sahu R; Walker LA; Tekwani BL
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to Glucantime of Leishmania viannia isolated from patients prior to treatment.
    Robledo SM; Valencia AZ; Saravia NG
    J Parasitol; 1999 Apr; 85(2):360-6. PubMed ID: 10219320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani.
    Seifert K; Munday J; Syeda T; Croft SL
    J Antimicrob Chemother; 2011 Apr; 66(4):850-4. PubMed ID: 21393188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of
    Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
    Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
    Vermeersch M; da Luz RI; Toté K; Timmermans JP; Cos P; Maes L
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3855-9. PubMed ID: 19546361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent.
    Seifert K; Escobar P; Croft SL
    J Antimicrob Chemother; 2010 Mar; 65(3):508-11. PubMed ID: 20089542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
    Carrió J; Portús M
    BMC Pharmacol; 2002 May; 2():11. PubMed ID: 12019027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.
    Sereno D; Holzmuller P; Lemesre JL
    Acta Trop; 2000 Jan; 74(1):25-31. PubMed ID: 10643904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.
    Sodhi S; Kaur S; Mahajan RC; Ganguly NK; Malla N
    Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():25-31. PubMed ID: 1322361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity.
    Borborema SE; Osso Junior JA; Andrade Junior HF; Nascimento Nd
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):196-203. PubMed ID: 27192589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.
    Pujals G; Suñé-Negre JM; Pérez P; García E; Portus M; Tico JR; Miñarro M; Carrió J
    Parasitol Res; 2008 May; 102(6):1243-7. PubMed ID: 18278586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo host and parasite response to antileishmanial drugs and immunomodulators.
    Gonzalez-Fajardo L; Fernández OL; McMahon-Pratt D; Saravia NG
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003820. PubMed ID: 26024228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of In vitro and In vivo Drug Efficacy Over Leishmania tropica: A Pilot Study.
    Özbilgin A; Çavuş İ; Yıldırım A; Kaya T; Ertabaklar H
    Turkiye Parazitol Derg; 2018 Mar; 42(1):11-19. PubMed ID: 29780014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.